155 related articles for article (PubMed ID: 19181522)
1. Beta-lactam-based approach for the chemical programming of aldolase antibody 38C2.
Gavrilyuk JI; Wuellner U; Barbas CF
Bioorg Med Chem Lett; 2009 Mar; 19(5):1421-4. PubMed ID: 19181522
[TBL] [Abstract][Full Text] [Related]
2. Multiple catalytic aldolase antibodies suitable for chemical programming.
Goswami RK; Huang ZZ; Forsyth JS; Felding-Habermann B; Sinha SC
Bioorg Med Chem Lett; 2009 Jul; 19(14):3821-4. PubMed ID: 19428247
[TBL] [Abstract][Full Text] [Related]
3. An efficient chemical approach to bispecific antibodies and antibodies of high valency.
Gavrilyuk JI; Wuellner U; Salahuddin S; Goswami RK; Sinha SC; Barbas CF
Bioorg Med Chem Lett; 2009 Jul; 19(14):3716-20. PubMed ID: 19497743
[TBL] [Abstract][Full Text] [Related]
4. A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy.
Rader C; Turner JM; Heine A; Shabat D; Sinha SC; Wilson IA; Lerner RA; Barbas CF
J Mol Biol; 2003 Sep; 332(4):889-99. PubMed ID: 12972259
[TBL] [Abstract][Full Text] [Related]
5. Preparation of integrin alpha(v)beta3-targeting Ab 38C2 constructs.
Sinha SC; Das S; Li LS; Lerner RA; Barbas CF
Nat Protoc; 2007; 2(2):449-56. PubMed ID: 17406606
[TBL] [Abstract][Full Text] [Related]
6. Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
Popkov M; Rader C; Gonzalez B; Sinha SC; Barbas CF
Int J Cancer; 2006 Sep; 119(5):1194-207. PubMed ID: 16570283
[TBL] [Abstract][Full Text] [Related]
7. A cofactor approach to copper-dependent catalytic antibodies.
Nicholas KM; Wentworth P; Harwig CW; Wentworth AD; Shafton A; Janda KD
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2648-53. PubMed ID: 11880619
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective aldol cyclodehydrations catalyzed by antibody 38C2.
List B; Lerner RA; Barbas CF
Org Lett; 1999 Jul; 1(1):59-61. PubMed ID: 10822533
[TBL] [Abstract][Full Text] [Related]
9. Chemically Programmed Bispecific Antibody Targeting Legumain Protease and αvβ3 Integrin Mediates Strong Antitumor Effects.
Liu Y; Goswami RK; Liu C; Sinha SC
Mol Pharm; 2015 Jul; 12(7):2544-50. PubMed ID: 26024761
[TBL] [Abstract][Full Text] [Related]
10. Aldol sensors for the rapid generation of tunable fluorescence by antibody catalysis.
List B; Barbas CF; Lerner RA
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15351-5. PubMed ID: 9860972
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of an organoinsulin molecule that can be activated by antibody catalysis.
Worrall DS; McDunn JE; List B; Reichart D; Hevener A; Gustafson T; Barbas CF; Lerner RA; Olefsky JM
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13514-8. PubMed ID: 11707596
[TBL] [Abstract][Full Text] [Related]
12. N-Sulfonyl-β-lactam hapten as an effective labeling reagent for aldolase mAb.
Inokuma T; Fuller RP; Barbas CF
Bioorg Med Chem Lett; 2015 Apr; 25(8):1684-1687. PubMed ID: 25791455
[TBL] [Abstract][Full Text] [Related]
13. Highly efficient antibody-catalyzed deuteration of carbonyl compounds.
Shulman A; Sitry D; Shulman H; Keinan E
Chemistry; 2002 Jan; 8(1):229-39. PubMed ID: 11822454
[TBL] [Abstract][Full Text] [Related]
14. Computational elucidation and validation of the three-dimensional structure of humanized aldolase catalytic antibody 38C2.
Jayakody RS; Jasin Arachchige LI; Japahuge A
J Biomol Struct Dyn; 2021 Apr; 39(7):2463-2477. PubMed ID: 32242499
[TBL] [Abstract][Full Text] [Related]
15. Evolution of aldolase antibodies in vitro: correlation of catalytic activity and reaction-based selection.
Tanaka F; Fuller R; Shim H; Lerner RA; Barbas CF
J Mol Biol; 2004 Jan; 335(4):1007-18. PubMed ID: 14698295
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of the aldolase antibody-derived chemical-antibodies targeting α5β1 integrin.
Goswami RK; Liu Y; Liu C; Lerner RA; Sinha SC
Mol Pharm; 2013 Feb; 10(2):538-43. PubMed ID: 23102054
[TBL] [Abstract][Full Text] [Related]
17. A catalytic antibody produces fluorescent tracers of gap junction communication in living cells.
Subauste MC; List B; Guan X; Hahn KM; Lerner R; Gilula NB
J Biol Chem; 2001 Dec; 276(52):49164-8. PubMed ID: 11606573
[TBL] [Abstract][Full Text] [Related]
18. An efficient benchtop system for multigram-scale kinetic resolutions using aldolase antibodies.
Turner JM; Bui T; Lerner RA; Barbas CF; List B
Chemistry; 2000 Aug; 6(15):2772-4. PubMed ID: 10985725
[TBL] [Abstract][Full Text] [Related]
19. Substrate-selective mechanisms in biocatalysis demonstrated with a versatile and efficient aldolase antibody.
Shulman H; Keinan E
Bioorg Med Chem Lett; 1999 Jul; 9(13):1745-50. PubMed ID: 10406635
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation.
Abraham S; Guo F; Li LS; Rader C; Liu C; Barbas CF; Lerner RA; Sinha SC
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5584-9. PubMed ID: 17372220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
